Origins of epilepsy in fragile X syndrome.
Fragile X syndrome is the leading heritable form of cognitive impairment and the leading known monogenic disorder associated with autism. Roughly one-quarter of children with this disorder have seizures, most of which are relatively benign and are resolved beyond childhood. Because of the prevalence of fragile X syndrome, numerous animal models have been developed and electrophysiological studies have taken place to investigate its pathogenesis. The investigations have yielded a wealth of information regarding the synaptic dysfunction that underlies the hyperexcitability and epileptiform features associated with this disorder.
Hagerman
Paul J
PJ
Department of Biochemistry and Molecular Medicine, University of California, School of Medicine, Davis, California, USA. pjhagerman@ucdavis.edu
Stafstrom
Carl E
CE
Proc Natl Acad Sci U S A. 1997 May 13;94(10):5395-400
9144248
Nat Chem Biol. 2008 Apr;4(4):256-63
18327252
Am J Med Genet B Neuropsychiatr Genet. 2009 Sep 5;150B(6):782-98
19105204
Genes Brain Behav. 2004 Dec;3(6):337-59
15544577
Cell. 2001 Nov 30;107(5):591-603
11733059
J Neurosci. 2005 Aug 31;25(35):8048-55
16135762
J Dev Behav Pediatr. 2008 Aug;29(4):293-302
18698192
Trends Neurosci. 2004 Jul;27(7):370-7
15219735
Am J Med Genet A. 2004 Sep 1;129A(3):225-34
15326621
J Neurophysiol. 2008 Nov;100(5):2615-26
18784272
Science. 2000 May 19;288(5469):1254-7
10818003
J Med Genet. 2009 Apr;46(4):266-71
19126569
Trends Neurosci. 2007 Aug;30(8):425-31
17590448
Dev Med Child Neurol. 2002 Nov;44(11):724-8
12418611
Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4429-34
18332424
Neurosci Lett. 2007 Feb 2;412(3):227-32
17197085
Proc Natl Acad Sci U S A. 2002 May 28;99(11):7746-50
12032354
Am J Med Genet A. 2008 Aug 1;146A(15):1911-6
18627038
Neurobiol Dis. 2006 Feb;21(2):346-57
16199166
Cereb Cortex. 2009 Jul;19(7):1504-14
18832330
J Neurosci. 2009 Mar 18;29(11):3497-507
19295155
J Med Genet. 2008 Aug;45(8):498-9
18413371
Neuron. 2007 Dec 20;56(6):955-62
18093519
Neuroscientist. 2009 Oct;15(5):549-67
19325170
Pediatrics. 2009 Jan;123(1):378-90
19117905
J Neurophysiol. 2000 May;83(5):2844-53
10805682
J Neurochem. 2007 Apr;101(2):411-21
17402970
J Neurosci. 2004 Jan 7;24(1):76-84
14715940
Proc Natl Acad Sci U S A. 2007 Sep 25;104(39):15537-42
17881561
Health Technol Assess. 2003;7(16):1-106
12969542
Neuron. 2008 Oct 23;60(2):201-14
18957214
Lancet Neurol. 2007 Jan;6(1):45-55
17166801
Brain Res. 2009 Feb 9;1253:176-83
19070606
Ment Retard Dev Disabil Res Rev. 2004;10(1):31-41
14994286
Neuropharmacology. 1999 Oct;38(10):1493-503
10530811
J Dev Behav Pediatr. 2006 Feb;27(1):63-74
16511373
J Neurophysiol. 2006 May;95(5):3291-5
16452252
Neurotherapeutics. 2009 Apr;6(2):392-401
19332335
Neurosci Lett. 2005 Apr 4;377(3):141-6
15755515
Dev Cell. 2008 Jun;14(6):926-39
18539120
J Neurosci. 2002 May 1;22(9):3795-805
11978855
Hum Mol Genet. 2006 Dec 1;15(23):3446-58
17065172
J Neurosci. 2001 Aug 15;21(16):6387-94
11487662
Neuropharmacology. 2005 Dec;49(7):1053-66
16054174
Brain Dev. 2002 Dec;24(8):766-9
12453600
Brain Res. 2006 Nov 22;1121(1):238-45
17046729
Neuron. 2005 Mar 3;45(5):753-64
15748850
Cereb Cortex. 2009 Jul;19(7):1515-20
18787232
Nat Rev Neurosci. 2005 May;6(5):376-87
15861180